Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Toxoplasma Gondii Gt1
SUBMITTER: Alice Herneisen
LAB HEAD: Sebastian Lourido
PROVIDER: PXD019917 | Pride | 2020-08-28
REPOSITORIES: pride
Action | DRS | |||
---|---|---|---|---|
20200118_DegP2_CETSA_heavy.mzML | Mzml | |||
20200118_DegP2_CETSA_heavy.mzid | Mzid | |||
20200118_DegP2_CETSA_light.mzML | Mzml | |||
20200118_DegP2_CETSA_light.mzid | Mzid | |||
20200217_DegP2_CETSA_plusRapa_10.raw | Raw |
Items per page: 5 1 - 5 of 31 |
Harding Clare R CR Sidik Saima M SM Petrova Boryana B Gnädig Nina F NF Okombo John J Herneisen Alice L AL Ward Kurt E KE Markus Benedikt M BM Boydston Elizabeth A EA Fidock David A DA Lourido Sebastian S
Nature communications 20200923 1
Artemisinins have revolutionized the treatment of Plasmodium falciparum malaria; however, resistance threatens to undermine global control efforts. To broadly explore artemisinin susceptibility in apicomplexan parasites, we employ genome-scale CRISPR screens recently developed for Toxoplasma gondii to discover sensitizing and desensitizing mutations. Using a sublethal concentration of dihydroartemisinin (DHA), we uncover the putative transporter Tmem14c whose disruption increases DHA susceptibil ...[more]